P3 Health Partners
PIII
51 hedge funds and large institutions have $124M invested in P3 Health Partners in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
67% more capital invested
Capital invested by funds: $74.1M → $124M (+$49.6M)
9% more funds holding
Funds holding: 47 → 51 (+4)
0.33% more ownership
Funds ownership: 0.98% → 1.31% (+0.33%)
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$33.1M |
| 2 |
BlackRock
New York
|
+$1.07M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$762K |
| 4 |
HF
HRT Financial
New York
|
+$249K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$172K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$831K |
| 2 |
Millennium Management
New York
|
-$439K |
| 3 |
EGM
Engineers Gate Manager
New York
|
-$115K |
| 4 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$93K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$69K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$750 | +3 | +100% |
|
|
EGM
52
Engineers Gate Manager
New York
| – | -$115K | -616 | Closed |
|
|
OQS
53
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
| – | -$93K | -499 | Closed |
|
|
SSA
54
Schonfeld Strategic Advisors
New York
| – | -$69K | -368 | Closed |
|
|
PCM
55
Penserra Capital Management
Orinda,
California
| – | -$9K | -50 | Closed |
|
PIII Hedge Fund Activity: Q3 2022 in Review
51 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in P3 Health Partners (PIII) for Q3 2022, worth a combined $124M — up 67% from $74.1M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new PIII positions and 4 closed out — a net gain of 4 holders — while 13 added to existing stakes and 15 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $33.1M. The largest seller was Vanguard Group, cutting an estimated $831K.
- 51 institutional investors held P3 Health Partners (PIII) as of Q3 2022, up from 47 in Q2 2022.
- Funds reported $124M of P3 Health Partners stock for Q3 2022, up 67% quarter-over-quarter.
- 8 funds opened new P3 Health Partners positions in Q3 2022 and 4 closed out, a net change of +4 holders.
- The largest P3 Health Partners buyer in Q3 2022 was Janus Henderson Group, an estimated $33.1M added.
- The largest P3 Health Partners seller in Q3 2022 was Vanguard Group, an estimated $831K sold.
Based on aggregated 13F filings for Q3 2022.